CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
The purpose of this study is to learn about the safety and effects of 2 study medicines (PF-07275315 and PF-07264660) for the treatment of atopic der...
Phase 2
Greenwood Village, Colorado, United States and 71 other locations
The primary objective of the study is to assess the long-term safety of dupilumab in pediatric participants with AD.The secondary objectives of the s...
Phase 3
Centennial, Colorado, United States and 83 other locations
This is a Phase 2, randomized, placebo/vehicle-controlled, double-blinded, multi-center trial. It is designed to assess the safety and efficacy of S....
Phase 2
Denver, Colorado, United States and 8 other locations
This is designed to assess the long-term safety and efficacy of lebrikizumab for moderate-to-severe atopic dermatitis. It will last up to 33 months.
Phase 3
Centennial, Colorado, United States and 320 other locations
The primary objective of this study is to describe the long-term safety and tolerability of rocatinlimab in participants with moderate-to-severe AD.
Phase 3
Centennial, Colorado, United States and 512 other locations
The objective of this study is to assess the efficacy and safety of upadacitinib for the treatment of adolescent and adult participants with moderate...
Phase 3
Lafayette, Colorado, United States and 194 other locations
The objective of this study is to assess the efficacy and safety of upadacitinib combined with topical corticosteroids (TCS) for the treatment of ado...
Phase 3
Aurora, Colorado, United States and 192 other locations
The purpose of this study is to evaluate the efficacy and safety of rocatinlimab in monotherapy treatment.
Phase 3
Centennial, Colorado, United States and 201 other locations
The purpose of this study is to evaluate the efficacy and safety of rocatinlimab in monotherapy and combination therapy treatment in adolescent parti...
Phase 3
Denver, Colorado, United States and 246 other locations
Clinical trials
Research sites
Resources
Legal